Singapore, 18 April 2024— Horizon Quantum Computing, a company building software development tools for quantum computers, today announced that it is establishing a first-of-a-kind testbed for integrating quantum computing hardware with...
ArgoMed developed a proprietary, water-induced thermotherapy device and technique to address the non-surgical treatment of benign prostatic hyperplasia (BPH). BPH is a condition that afflicts the majority of men over 60, causing adverse changes in urinary voiding patterns. ArgoMed's initial product received FDA market approval in 1999, before the company’s assets were acquired by Circon in 2002.
ArgoMed
Cary, NC
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.